214 related articles for article (PubMed ID: 31522433)
1. Alteration of Serum Levels of Cytokines in Schizophrenic Patients before and after Treatment with Risperidone.
Azizi E; Zavaran Hosseini A; Soudi S; Noorbala AA
Iran J Allergy Asthma Immunol; 2019 Jun; 18(3):262-268. PubMed ID: 31522433
[TBL] [Abstract][Full Text] [Related]
2. Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment.
Erbağci AB; Herken H; Köylüoglu O; Yilmaz N; Tarakçioglu M
Mediators Inflamm; 2001 Jun; 10(3):109-15. PubMed ID: 11545247
[TBL] [Abstract][Full Text] [Related]
3. Minocycline adjunctive treatment to risperidone for negative symptoms in schizophrenia: Association with pro-inflammatory cytokine levels.
Zhang L; Zheng H; Wu R; Zhu F; Kosten TR; Zhang XY; Zhao J
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jul; 85():69-76. PubMed ID: 29678772
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of the changes of serum high mobility group protein B1 and cytokines in first-episode schizophrenia patients].
Zhu Q; Li X; Hie G; Yuan X; Lü L; Song X
Zhonghua Yi Xue Za Zhi; 2015 Dec; 95(47):3818-22. PubMed ID: 27337797
[TBL] [Abstract][Full Text] [Related]
5. The interaction of nuclear factor-kappa B and cytokines is associated with schizophrenia.
Song XQ; Lv LX; Li WQ; Hao YH; Zhao JP
Biol Psychiatry; 2009 Mar; 65(6):481-8. PubMed ID: 19058794
[TBL] [Abstract][Full Text] [Related]
6. Cytokine profiles in schizophrenic patients treated with risperidone: a 3-month follow-up study.
Cazzullo CL; Sacchetti E; Galluzzo A; Panariello A; Adorni A; Pegoraro M; Bosis S; Colombo F; Trabattoni D; Zagliani A; Clerici M
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jan; 26(1):33-9. PubMed ID: 11853116
[TBL] [Abstract][Full Text] [Related]
7. Serum TNF-α, IL-10 and IL-2 in schizophrenic patients before and after treatment with risperidone and clozapine.
Ajami A; Abedian F; Hamzeh Hosseini S; Akbarian E; Alizadeh-Navaei R; Taghipour M
Iran J Immunol; 2014 Sep; 11(3):200-9. PubMed ID: 25265997
[TBL] [Abstract][Full Text] [Related]
8. Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia.
Zhang XY; Zhou DF; Cao LY; Zhang PY; Wu GY; Shen YC
J Clin Psychiatry; 2004 Jul; 65(7):940-7. PubMed ID: 15291683
[TBL] [Abstract][Full Text] [Related]
9. Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug naïve, first-episode schizophrenia.
Song X; Fan X; Li X; Zhang W; Gao J; Zhao J; Harrington A; Ziedonis D; Lv L
Psychopharmacology (Berl); 2014 Jan; 231(2):319-25. PubMed ID: 24337064
[TBL] [Abstract][Full Text] [Related]
10. [Effect of clozapine and risperidone on serum cytokine levels in patients with first-episode paranoid schizophrenia].
Lü LX; Guo SQ; Chen W; Li Q; Cheng J; Guo JH
Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1251-4. PubMed ID: 15567770
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic treatment may alter T-helper (TH) 2 arm cytokines.
Pae CU; Yoon CH; Kim TS; Kim JJ; Park SH; Lee CU; Lee SJ; Lee C; Paik IH
Int Immunopharmacol; 2006 Apr; 6(4):666-71. PubMed ID: 16504930
[TBL] [Abstract][Full Text] [Related]
12. Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics.
Zhang XY; Zhou DF; Cao LY; Wu GY; Shen YC
Neuropsychopharmacology; 2005 Aug; 30(8):1532-8. PubMed ID: 15886721
[TBL] [Abstract][Full Text] [Related]
13. Monocytic, Th1 and th2 cytokine alterations in the pathophysiology of schizophrenia.
Na KS; Kim YK
Neuropsychobiology; 2007; 56(2-3):55-63. PubMed ID: 18037815
[TBL] [Abstract][Full Text] [Related]
14. Effect of risperidone on serum cytokines.
Kim DJ; Kim W; Yoon SJ; Go HJ; Choi BM; Jun TY; Kim YK
Int J Neurosci; 2001; 111(1-2):11-9. PubMed ID: 11913333
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of interleukin-6 and tumor necrosis factor-alpha in exacerbation and remission phase of schizophrenia.
Dunjic-Kostic B; Jasovic-Gasic M; Ivkovic M; Radonjic NV; Pantovic M; Damjanovic A; Poznanovic ST; Jovanovic A; Nikolic T; Petronijevic ND
Psychiatr Danub; 2013 Mar; 25(1):55-61. PubMed ID: 23470607
[TBL] [Abstract][Full Text] [Related]
16. Fasting insulin serum levels and psychopathology profiles in male schizophrenic inpatients treated with olanzapine or risperidone.
Konarzewska B; Waszkiewicz N; Galińska B; Szulc A
Neuro Endocrinol Lett; 2013; 34(4):322-8. PubMed ID: 23803867
[TBL] [Abstract][Full Text] [Related]
17. Increased Interleukin-17 and decreased BAFF serum levels in drug-free acute schizophrenia.
El Kissi Y; Samoud S; Mtiraoui A; Letaief L; Hannachi N; Ayachi M; Ali BBH; Boukadida J
Psychiatry Res; 2015 Jan; 225(1-2):58-63. PubMed ID: 25453636
[TBL] [Abstract][Full Text] [Related]
18. Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics.
Zhang XY; Zhou DF; Qi LY; Chen S; Cao LY; Chen DC; Xiu MH; Wang F; Wu GY; Lu L; Kosten TA; Kosten TR
Psychopharmacology (Berl); 2009 May; 204(1):177-84. PubMed ID: 19139851
[TBL] [Abstract][Full Text] [Related]
19. Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia: a randomized, double-blind, placebo-controlled, clinical trial.
Hosseini SM; Farokhnia M; Rezaei F; Gougol A; Yekehtaz H; Iranpour N; Salehi B; Tabrizi M; Tajdini M; Ghaleiha A; Akhondzadeh S
Eur Neuropsychopharmacol; 2014 Jun; 24(6):846-55. PubMed ID: 24636461
[TBL] [Abstract][Full Text] [Related]
20. Serum cytokine profile in schizophrenic patients.
Eftekharian MM; Omrani MD; Arsang-Jang S; Taheri M; Ghafouri-Fard S
Hum Antibodies; 2019; 27(1):23-29. PubMed ID: 30103309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
